<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id>
      <journal-title-group>
        <journal-title>Cancer Imaging</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1740-5025</issn>
      <issn pub-type="epub">1470-7330</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28086986</article-id>
      <article-id pub-id-type="pmc">5237176</article-id>
      <article-id pub-id-type="publisher-id">105</article-id>
      <article-id pub-id-type="doi">10.1186/s40644-016-0105-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Series</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Radioiodine sinus uptake related to mucosal thickening or aspergilloma: a case series of an unrecognized event well evidenced by SPECT/CT</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ciappuccini</surname>
            <given-names>Renaud</given-names>
          </name>
          <address>
            <phone>+33 231 455 032</phone>
            <email>r.ciappuccini@baclesse.unicancer.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Blanchard</surname>
            <given-names>David</given-names>
          </name>
          <address>
            <email>d.blanchard@baclesse.unicancer.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rame</surname>
            <given-names>Jean-Pierre</given-names>
          </name>
          <address>
            <email>my.louis@baclesse.unicancer.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Raucourt</surname>
            <given-names>Dominique</given-names>
          </name>
          <address>
            <email>dderaucourt@baclesse.unicancer.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Babin</surname>
            <given-names>Emmanuel</given-names>
          </name>
          <address>
            <email>babin-e@chu-caen.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bardet</surname>
            <given-names>St&#xE9;phane</given-names>
          </name>
          <address>
            <email>s.bardet@baclesse.unicancer.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Nuclear Medicine and Thyroid Unit, Fran&#xE7;ois Baclesse Cancer Centre, 3 Avenue G&#xE9;n&#xE9;ral Harris - BP 5026, F-14076 CAEN Cedex 05, France </aff>
        <aff id="Aff2"><label>2</label>INSERM U1086 &#x201C;Cancers et Pr&#xE9;ventions&#x201D;, Fran&#xE7;ois Baclesse Cancer Centre, Caen, France </aff>
        <aff id="Aff3"><label>3</label>Department of Head and Neck Surgery, Fran&#xE7;ois Baclesse Cancer Centre, Caen, France </aff>
        <aff id="Aff4"><label>4</label>Department of Head and Neck Surgery, University Hospital, Caen, France </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>13</day>
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>17</volume>
      <elocation-id>2</elocation-id>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>11</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>12</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2017</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>False-positive radioiodine (RAI) uptake related to chronic sinusitis and mucocele has only rarely been reported in patients with differentiated thyroid cancer (DTC) even with the recent use of single photon emission tomography with computed tomography (SPECT/CT) acquisition. No other etiology of sinus RAI uptake has been mentioned to date.</p>
        </sec>
        <sec>
          <title>Objectives</title>
          <p>We report five cases of DTC patients with sinus RAI uptake on post-RAI scintigraphy. SPECT/CT clearly localized RAI uptake either in the sphenoid, the maxillary or the frontal sinus and highly suspected mucosal thickening in four patients and sinus aspergilloma in one patient.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>These data confirm the possibility of false-positive sinus RAI uptake, provide a new cause of such benign uptake, i.e. sinus aspergilloma, and demonstrate the clinical relevance of head and neck SPECT/CT acquisition in the diagnosis of such uptake. Nuclear medicine physicians should be aware of this pitfall when interpreting post-RAI scintigraphy.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Differentiated thyroid cancer</kwd>
        <kwd>Radioiodine</kwd>
        <kwd>SPECT/CT</kwd>
        <kwd>Sinus</kwd>
        <kwd>Aspergilloma</kwd>
        <kwd>Case report</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>False-positive radioiodine (RAI) uptake in chronic frontal sinusitis was reported once in a patient with differentiated thyroid cancer (DTC) [<xref ref-type="bibr" rid="CR1">1</xref>] and in mucocele [<xref ref-type="bibr" rid="CR2">2</xref>] twenty years ago using planar imaging. Although single photon emission tomography with computed tomography (SPECT/CT) neck acquisition is commonly used in both diagnostic [<xref ref-type="bibr" rid="CR3">3</xref>] and post-therapeutic settings [<xref ref-type="bibr" rid="CR4">4</xref>&#x2013;<xref ref-type="bibr" rid="CR7">7</xref>], there is still no other published report of RAI uptake in sinuses, especially in the maxillary or sphenoid ones. Furthermore, no cause other than chronic sinusitis or mucocele has evoked to explain sinus RAI uptake. We report here several cases of DTC patients showing RAI uptake in various sinuses (frontal, maxillary or sphenoid sinus), most of them being related to sinus mucosal thickening and one to a pathologically confirmed aspergilloma in a maxillary sinus. Each of these cases was clearly evidenced by SPECT/CT images.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <sec id="Sec3">
        <title>Case 1</title>
        <sec id="Sec4">
          <title>Sphenoid sinus</title>
          <p>A 61-year-old woman with papillary thyroid cancer (pT1b N0 Mx) was referred to our department in August 2010 for RAI ablation. Whole-body scan (WBS) with neck and thorax SPECT/CT (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) was performed five days after administration of 4110&#xA0;MBq (111&#xA0;mCi) of RAI after recombinant human thyrotropin (rhTSH) stimulation. Stimulated thyroglobulin (Tg) was very low at 0.1&#xA0;ng/ml without serum Tg antibodies (TgAb). WBS depicted an RAI focus in the nose related to nasal RAI excretion and a left-sided moderate uptake, also suggesting physiological excretion. Interestingly, SPECT/CT showed that the latter uptake was located in the sphenoid sinus with mucosal thickening. The patient had no symptoms. Sinus mucosal thickening had disappeared on the CT scan control in 2014 and she was disease-free at the last visit in October 2016.<fig id="Fig1"><label>Fig. 1</label><caption><p>Planar acquisition (anterior view, Panel <bold>a</bold>), fused (Panel <bold>d</bold>) and CT (Panel <bold>e</bold>) images of SPECT/CT acquisition displaying RAI uptake in the left sphenoid sinus with mucosal thickening on CT scan slices (<italic>blue arrow</italic>). RAI uptake is also present in the nose (Panels <bold>a</bold>, <bold>b</bold> and <bold>c</bold>, <italic>red arrow</italic>)</p></caption><graphic xlink:href="40644_2016_105_Fig1_HTML" id="MO1"/></fig>
</p>
        </sec>
      </sec>
      <sec id="Sec5">
        <title>Case 2</title>
        <sec id="Sec6">
          <title>Frontal sinus</title>
          <p>A 51-year-old woman with a 15-mm papillary thyroid cancer with microscopic extrathyroid extension and central node involvement (pT3 N1a Mx) was referred for RAI ablation in January 2015. She was given 3570&#xA0;MBq (96&#xA0;mCi) of RAI after rhTSH. The stimulated Tg level was 0.3&#xA0;ng/ml in the presence of serum TgAb. Five days after treatment, WBS evidenced focal RAI uptake in the right part of the skull. SPECT/CT acquisition ruled out bone metastasis and showed this uptake in the right frontal sinus to be associated with mucosal thickening (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). The patient had no symptoms and was disease-free at the last visit in October 2016.<fig id="Fig2"><label>Fig. 2</label><caption><p>Planar acquisition (anterior view, Panel <bold>a</bold>), fused (Panel <bold>b</bold>) and CT (Panel <bold>c</bold>) images of SPECT/CT acquisition displaying RAI uptake in the right part of the frontal sinus with mucosal thickening on CT scan slices (<italic>red arrow</italic>). RAI uptake is also visible in the nose (Panels <bold>a</bold>, <bold>d</bold> and <bold>e</bold>, <italic>blue arrow</italic>)</p></caption><graphic xlink:href="40644_2016_105_Fig2_HTML" id="MO2"/></fig>
</p>
        </sec>
      </sec>
      <sec id="Sec7">
        <title>Case 3</title>
        <sec id="Sec8">
          <title>Frontal sinus</title>
          <p>An 81-year-old woman with a papillary thyroid cancer with lymph node involvement and microscopic extrathyroid extension (pT3 N1b Mx) was given 3681&#xA0;MBq (99&#xA0;mCi) of RAI in September 2015. The stimulated Tg level was 67&#xA0;ng/ml. Post-ablation WBS depicted a faint RAI uptake in the anterior right part of the skull. SPECT/CT acquisition showed that this uptake was related to mucosal thickening in the frontal sinus (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). For the sake of comparison, an example of a bone metastasis of the skull which was faintly RAI-avid and well depicted by SPECT/CT acquisition is presented in Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>. Three months after RAI ablation, Tg level was at 22&#xA0;ng/ml on levothyroxine. 18-Fluorodeoxyglucose positron emission tomography with computed tomography (18&#xA0;F-FDG PET/CT) was performed in October 2016 and did not show any abnormal FDG uptake. We assumed that the patient had biochemical persistence of disease.<fig id="Fig3"><label>Fig. 3</label><caption><p>Planar acquisition (anterior view, Panel <bold>a</bold>), CT (Panel <bold>b</bold>) and fused (Panel <bold>c</bold>) images of SPECT/CT acquisition displaying a faint RAI uptake in the right part of the frontal sinus with mucosal thickening on CT scan slices (<italic>blue arrow</italic>)</p></caption><graphic xlink:href="40644_2016_105_Fig3_HTML" id="MO3"/></fig>
<fig id="Fig4"><label>Fig. 4</label><caption><p>A 56-year-old male patient complained of back pain related to a lytic bone metastasis which led to the discovery of a follicular thyroid cancer. Post-ablation scintigraphy in March 2012 evidenced an intense RAI uptake in front of the spinal metastasis and other uptake in a rib and in the skull. Planar acquisition (posterior view, Panel <bold>a</bold>), SPECT (Panel <bold>b</bold>) and fused (Panel <bold>c</bold>) images of SPECT/CT acquisition displaying the faint RAI uptake in the left part of the skull are consistent with bone metastasis</p></caption><graphic xlink:href="40644_2016_105_Fig4_HTML" id="MO4"/></fig>
</p>
        </sec>
      </sec>
      <sec id="Sec9">
        <title>Case 4</title>
        <sec id="Sec10">
          <title>Maxillary sinus</title>
          <p>A 49-year-old woman was referred for RAI ablation in April 2014 two months after total thyroidectomy for a 6-cm Hurtle cell carcinoma. She was given 3770&#xA0;MBq (102&#xA0;mCi) of RAI after rhTSH stimulation. The stimulated Tg level was low at 0.3&#xA0;ng/ml without serum TgAb. WBS performed five days after treatment showed a right-sided moderate focus close to the nose suggesting physiologic excretion. On SPECT/CT this focus was clearly located in the right maxillary sinus, which showed mucosal thickening. SPECT/CT also revealed a faint uptake in the left maxillary sinus which was not seen on WBS (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). The patient had no symptoms and was disease-free at the last visit in February 2016.<fig id="Fig5"><label>Fig. 5</label><caption><p>Planar acquisition (anterior view, Panel <bold>a</bold>), CT (Panel <bold>b</bold>) and fused (Panel <bold>c</bold>) images of SPECT/CT acquisition displaying RAI uptake in both the right maxillary sinus (<italic>red arrow</italic>) and the left one (<italic>blue arrow</italic>) with bilateral mucosal thickening on CT scan slices</p></caption><graphic xlink:href="40644_2016_105_Fig5_HTML" id="MO5"/></fig>
</p>
        </sec>
      </sec>
      <sec id="Sec11">
        <title>Case 5</title>
        <sec id="Sec12">
          <title>Maxillary sinus</title>
          <p>A 38-year-old woman with a pT3 N1b M0 papillary thyroid cancer treated six years before by surgery and RAI ablation presented with an increased serum Tg level at 20&#xA0;ng/ml on levothyroxine. Neck ultrasound examination did not show any abnormal lymph nodes. After a multidisciplinary staff meeting, she was given a second RAI treatment after rhTSH in June 2014, 1820&#xA0;MBq (49&#xA0;mCi). Stimulated Tg level was 61&#xA0;ng/ml without serum TgAb. WBS performed two days after RAI administration depicted an intense focal uptake in the left part of the face which was not present on the post-ablation WBS in August 2008 (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>). Complementary head and neck SPECT/CT ruled out a bone lesion and showed that RAI uptake was located in the left maxillary sinus. Hybrid CT scan evidenced a typical feature of aspergilloma with a dense soft-tissue mass including a calcification, strongly suggesting a fungus ball (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>). The patient also complained of a stuffy nose. As WBS with SPECT/CT did not display malignant RAI foci, 18&#xA0;F-FDG PET/CT was performed and evidenced FDG nodal uptake in the upper mediastinum. The patient was operated on in September 2014 with sternotomy to remove the FDG-avid lymph node. Pathology confirmed malignancy. She then underwent left sinus meatotomy endoscopically in February 2015 with removal of the fungus ball (Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>). The stuffy nose complaint disappeared after surgery. At the last visit in April 2016, she was disease-free with a serum Tg level at 0.5&#xA0;ng/ml.<fig id="Fig6"><label>Fig. 6</label><caption><p>WBS after RAI ablation in August 2008 (Panel <bold>a</bold>) and WBS performed two days after the second RAI administration in June 2014 (Panel <bold>b</bold>) in the same female patient with increased serum Tg level. An intense focal RAI uptake was observed in the left part of the face in June 2014 (<italic>arrow</italic>) which was not present on the previous WBS</p></caption><graphic xlink:href="40644_2016_105_Fig6_HTML" id="MO6"/></fig>
<fig id="Fig7"><label>Fig. 7</label><caption><p>Complementary head and neck SPECT/CT was performed and confirmed that RAI uptake (fused images, Panels <bold>c</bold> &amp; <bold>d</bold>) was located in the left maxillary sinus (hybrid CT scan images, Panels <bold>a</bold> &amp; <bold>b</bold>, blue arrow). Hybrid CT scan evidenced a typical feature of aspergilloma with a dense soft-tissue mass including a calcification, suggesting a fungus ball</p></caption><graphic xlink:href="40644_2016_105_Fig7_HTML" id="MO7"/></fig>
<fig id="Fig8"><label>Fig. 8</label><caption><p>The patient underwent left sinus meatotomy endoscopically in February 2015 with removal of the fungus ball</p></caption><graphic xlink:href="40644_2016_105_Fig8_HTML" id="MO8"/></fig>
</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec13">
      <title>Discussion</title>
      <p>This report describes five DTC patients in whom post-RAI SPECT/CT acquisition revealed benign RAI uptake in various sinuses (sphenoid, frontal or maxillary sinus) related to mucosal thickening in four patients and to aspergilloma in one. RAI sinus uptake has rarely been reported in the literature. Using planar imaging in 1994, Bakheet et al. reported frontal RAI uptake in a patient with chronic sinusitis [<xref ref-type="bibr" rid="CR1">1</xref>]. In 1997, also with planar imaging, Matheja et al. described frontal RAI uptake in a patient with mucocele [<xref ref-type="bibr" rid="CR2">2</xref>]. In a recent pictorial review using SPECT/CT [<xref ref-type="bibr" rid="CR8">8</xref>], Glazer et al. listed unusual physiological RAI biodistributions at the head and neck level but no sinus uptake SPECT/CT image was presented. Our five case reports confirm the reality of sinus uptake and demonstrate that such benign uptake is not uncommon when SPECT/CT is routinely performed in combination with WBS.</p>
      <p>In Case 3, despite the lack of histopathologic confirmation and the persistence of detectable Tg level without identifiable structural lesion, we concluded that sinus uptake was benign based on the pattern of RAI uptake on WBS with SPECT/CT.</p>
      <p>In four patients without any symptom of sinusitis, incidental RAI uptake was due to sinus mucosal thickening. The mechanism of RAI sinus uptake remains elusive. As previously suggested [<xref ref-type="bibr" rid="CR1">1</xref>], it might be due to the accumulation of inflammatory nasal secretions in the sinuses. As RAI is excreted in the salivary glands and the nose, moderate uptake in the maxillary and sphenoid sinuses can mimic physiological excretion and might remain unknown on WBS. Interestingly, RAI uptake was clearly related to aspergilloma in a maxillary sinus in the fifth patient. To our knowledge, this is the first such case to be reported although false-positive lung RAI uptake due to aspergillosis has already been documented [<xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR11">11</xref>]. Various fungi are known to be able to take up iodine-125 [<xref ref-type="bibr" rid="CR12">12</xref>]. RAI uptake might be due to the presence of oxidants/antioxidants at sites of inflammation or to endotoxins or enzymes released by the fungus. However, the exact mechanism of such an accumulation in fungal cells remains unknown.</p>
      <p>Thanks to its ability to localize RAI foci accurately on hybrid low-dose CT scans, SPECT/CT imaging has considerably altered the interpretation of planar scintigraphy in the last ten years. The improvement due to SPECT/CT is particularly significant when anatomical landmarks are obviously lacking as on post-RAI scintigraphy. Specifically, SPECT/CT was highly suggestive of aspergilloma on the hybrid CT scan without the need for further examinations in Case 5.</p>
    </sec>
    <sec id="Sec14">
      <title>Conclusions</title>
      <p>In conclusion, false-positive RAI uptake in various sinuses related to mucosal thickening and aspergilloma is possible in patients with DTC and is well demonstrated by SPECT/CT images. Nuclear medicine physicians should be aware of such benign uptake when interpreting post-RAI scintigraphy.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>18&#xA0;F-FDG PET/CT</term>
          <def>
            <p>18-Fluorodeoxyglucose positron emission tomography with computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>DTC</term>
          <def>
            <p>Differentiated thyroid cancer</p>
          </def>
        </def-item>
        <def-item>
          <term>RAI</term>
          <def>
            <p>Radioiodine</p>
          </def>
        </def-item>
        <def-item>
          <term>rhTSH</term>
          <def>
            <p>Recombinant human thyrotropin</p>
          </def>
        </def-item>
        <def-item>
          <term>SPECT/CT</term>
          <def>
            <p>Single photon emission tomography with computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>Tg</term>
          <def>
            <p>Thyroglobulin</p>
          </def>
        </def-item>
        <def-item>
          <term>TgAb</term>
          <def>
            <p>Thyroglobulin antibodies</p>
          </def>
        </def-item>
        <def-item>
          <term>WBS</term>
          <def>
            <p>Whole-body scan</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>We thank Sophie Taillard for assistance in preparation of the manuscript.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>No funding was received.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>The datasets analyzed during the current study are available from the corresponding author on reasonable request.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>RC conceived the study. RC and SB drafted the manuscript. RC, DB, JPR, DDR, EB and SB participated to data acquisition, analysis and interpretation. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the patients.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>All patients provided an informed consent for the use of personal data. Therefore, for this retrospective analysis ethics committee approval was not requested. All data, including images, were anonymized and all patients provided their consent for the use of personal data.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bakheet</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hammami</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology</article-title>
          <source>Clin Nucl Med</source>
          <year>1994</year>
          <volume>19</volume>
          <fpage>325</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="doi">10.1097/00003072-199404000-00010</pub-id>
          <pub-id pub-id-type="pmid">8004865</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matheja</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lerch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Kuwert</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schober</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Frontal sinus mucocele mimicking a metastasis of papillary thyroid carcinoma</article-title>
          <source>J Nucl Med</source>
          <year>1997</year>
          <volume>38</volume>
          <fpage>1022</fpage>
          <lpage>1024</lpage>
          <pub-id pub-id-type="pmid">9225783</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Avram</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Fig</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KK</given-names>
            </name>
          </person-group>
          <article-title>Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2013</year>
          <volume>98</volume>
          <fpage>1163</fpage>
          <lpage>1171</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2012-3630</pub-id>
          <pub-id pub-id-type="pmid">23430789</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aide</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Heutte</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rame</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Rousseau</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Loiseau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Henry-Amar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bardet</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131) I scintigraphy for thyroid cancer</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2009</year>
          <volume>94</volume>
          <fpage>2075</fpage>
          <lpage>2084</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2008-2313</pub-id>
          <pub-id pub-id-type="pmid">19276233</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bardet</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ciappuccini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Quak</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rame</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Blanchard D, de RD, Babin E, Michels JJ, Vaur D, Heutte N: Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2015</year>
          <volume>100</volume>
          <fpage>132</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2014-1199</pub-id>
          <pub-id pub-id-type="pmid">25303481</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Szikszai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Linke</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bautz</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kuwert</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation</article-title>
          <source>J Nucl Med</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>18</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.2967/jnumed.108.052746</pub-id>
          <pub-id pub-id-type="pmid">19091884</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spanu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Solinas</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Chessa</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sanna</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nuvoli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Madeddu</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging</article-title>
          <source>J Nucl Med</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>184</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="doi">10.2967/jnumed.108.056572</pub-id>
          <pub-id pub-id-type="pmid">19164225</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glazer</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Savas</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Avram</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretation</article-title>
          <source>Radiographics</source>
          <year>2013</year>
          <volume>33</volume>
          <fpage>397</fpage>
          <lpage>418</lpage>
          <pub-id pub-id-type="doi">10.1148/rg.332125051</pub-id>
          <pub-id pub-id-type="pmid">23479704</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahn</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer</article-title>
          <source>Thyroid</source>
          <year>2011</year>
          <volume>21</volume>
          <fpage>555</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="doi">10.1089/thy.2010.0448</pub-id>
          <pub-id pub-id-type="pmid">21449768</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manka-Waluch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Palmedo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tasci</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Biersack</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Bucerius</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>False-positive 131I whole-body scan and shrinkage of a pulmonary aspergilloma under 131I therapy in a patient with thyroid cancer</article-title>
          <source>Thyroid</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>197</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="doi">10.1089/thy.2006.16.197</pub-id>
          <pub-id pub-id-type="pmid">16676412</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pina</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Billingsley</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Matlock</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Horan</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Knodel</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory diseases of the lung causing false-positive 131iodine whole body scans in the evaluation of papillary thyroid carcinoma. Two case reports</article-title>
          <source>Chest</source>
          <year>1996</year>
          <volume>110</volume>
          <fpage>565</fpage>
          <lpage>567</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.110.2.565</pub-id>
          <pub-id pub-id-type="pmid">8697869</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ban-nai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Muramatsu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Amachi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Rate of iodine volatilization and accumulation by filamentous fungi through laboratory cultures</article-title>
          <source>Chemosphere</source>
          <year>2006</year>
          <volume>65</volume>
          <fpage>2216</fpage>
          <lpage>2222</lpage>
          <pub-id pub-id-type="doi">10.1016/j.chemosphere.2006.05.047</pub-id>
          <pub-id pub-id-type="pmid">16828143</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
